Exome Asset Management LLC — 13F Holdings & Portfolio
CIK 2011932 · latest 13F-HR filed 2026-08-14
Exome Asset Management LLC manages $162.1M in 13F-reported U.S. long-equity assets across 52 reported positions as of its 2026-06-30 13F-HR filing. Its largest disclosed positions are GH (6.25%), PRAX (5.62%), TGTX (5.59%). Quarter over quarter (versus its 2026-03-31 filing) the fund opened 15 new positions, exited 8, added to 9, and trimmed 24.
AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.
NEW YORK, NY 10017
$162.1M
Long-equity book
52
Distinct positions
2026-06-30
Filed 2026-08-14
+15 / −8 / ↑9 / ↓24
vs 2026-03-31
| Name | Title / Status | Ownership | Type |
|---|
Top Adds (vs prior quarter)
- GUARDANT HEALTH INC$2.5M +32.5%
- LIQUIDIA CORPORATION$1.4M +80.9%
- MAZE THERAPEUTICS INC$780.4K +29.5%
- 10X GENOMICS INC$661.3K +20.2%
- GLAUKOS CORP$528.6K +23.5%
Top Trims
- PRAXIS PRECISION MEDICINES I-$5.5M -37.8%
- BRIDGEBIO PHARMA INC-$3.6M -72.7%
- ENLIVEN THERAPEUTICS INC-$3.5M -41.1%
- INSMED INC-$2.9M -66.1%
- COGENT BIOSCIENCES INC-$2.6M -24.0%
New Positions
- TG THERAPEUTICS INC$9.1M
- ABIVAX SA$6.2M
- UNIQURE NV$3.7M
- ASTRAZENECA PLC$2.3M
- VIKING THERAPEUTICS INC$1.9M
Exited Positions
- ELEVANCE HEALTH INC FORMERLY$4.3M
- APELLIS PHARMACEUTICALS INC$3.4M
- AVALO THERAPEUTICS INC$2.4M
- SOLENO THERAPEUTICS INC$2.1M
- 4D MOLECULAR THERAPEUTICS IN$1.2M
Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).
| # | Issuer | Symbol | CUSIP | Value | Weight | Shares | Type |
|---|---|---|---|---|---|---|---|
| 1 | GUARDANT HEALTH INC | GH | 40131M109 | $10.1M | 6.25% | 67,500 | SH |
| 2 | PRAXIS PRECISION MEDICINES I | PRAX | 74006W207 | $9.1M | 5.62% | 27,205 | SH |
| 3 | TG THERAPEUTICS INC | TGTX | 88322Q108 | $9.1M | 5.59% | 164,915 | SH |
| 4 | COGENT BIOSCIENCES INC | COGT | 19240Q201 | $8.1M | 5.03% | 210,523 | SH |
| 5 | IONIS PHARMACEUTICALS INC | IONS | 462222100 | $7.0M | 4.31% | 88,177 | SH |
| 6 | ELI LILLY & CO | LLY | 532457108 | $6.6M | 4.06% | 5,492 | SH |
| 7 | ABIVAX SA | ABVX | 00370M103 | $6.2M | 3.85% | 46,878 | SH |
| 8 | ALUMIS INC | ALMS | 022307102 | $5.8M | 3.55% | 204,418 | SH |
| 9 | CYTOKINETICS INC | CYTK | 23282W605 | $5.1M | 3.16% | 60,056 | SH |
| 10 | ENLIVEN THERAPEUTICS INC | ELVN | 29337E102 | $5.1M | 3.14% | 100,203 | SH |
| 11 | VERA THERAPEUTICS INC | VERA | 92337R101 | $4.2M | 2.57% | 97,276 | SH |
| 12 | UNITEDHEALTH GROUP INC | UNH | 91324P102 | $4.0M | 2.46% | 9,612 | SH |
| 13 | 10X GENOMICS INC | TXG | 88025U109 | $3.9M | 2.43% | 102,629 | SH |
| 14 | NATERA INC | NTRA | 632307104 | $3.7M | 2.31% | 13,800 | SH |
| 15 | UNIQURE NV | QURE | N90064101 | $3.7M | 2.30% | 81,056 | SH |
| 16 | RHYTHM PHARMACEUTICALS INC | RYTM | 76243J105 | $3.6M | 2.21% | 32,209 | SH |
| 17 | MAZE THERAPEUTICS INC | MAZE | 578784100 | $3.4M | 2.11% | 114,692 | SH |
| 18 | MONTE ROSA THERAPEUTICS INC | GLUE | 61225M102 | $3.3M | 2.05% | 137,115 | SH |
| 19 | MOONLAKE IMMUNOTHERAPEUTICS | MLTX | 61559X104 | $3.2M | 2.00% | 166,493 | SH |
| 20 | ALKERMES PLC | ALKS | G01767105 | $3.2M | 1.98% | 61,336 | SH |
| 21 | LIQUIDIA CORPORATION | LQDA | 53635D202 | $3.1M | 1.93% | 39,224 | SH |
| 22 | UNITED THERAPEUTICS CORP DEL | UTHR | 91307C102 | $2.9M | 1.81% | 5,410 | SH |
| 23 | GLAUKOS CORP | GKOS | 377322102 | $2.8M | 1.71% | 19,862 | SH |
| 24 | ARROWHEAD PHARMACEUTICALS IN | ARWR | 04280A100 | $2.6M | 1.62% | 32,214 | SH |
| 25 | AGIOS PHARMACEUTICALS INC | AGIO | 00847X104 | $2.6M | 1.61% | 70,500 | SH |
| 26 | CRESCENT BIOPHARMA INC. | CBIO | G2545C104 | $2.3M | 1.42% | 127,769 | SH |
| 27 | ASTRAZENECA PLC | AZN | G0593M107 | $2.3M | 1.39% | 12,045 | SH |
| 28 | BOSTON SCIENTIFIC CORP | BSX | 101137107 | $2.1M | 1.27% | 48,347 | SH |
| 29 | ADAGENE INC | ADAG | 005329107 | $2.1M | 1.27% | 488,293 | SH |
| 30 | PENUMBRA INC | PEN | 70975L107 | $2.0M | 1.23% | 6,300 | SH |
| 31 | INTUITIVE SURGICAL INC | ISRG | 46120E602 | $2.0M | 1.20% | 4,908 | SH |
| 32 | VIKING THERAPEUTICS INC | VKTX | 92686J106 | $1.9M | 1.15% | 47,861 | SH |
| 33 | OCULAR THERAPEUTIX INC | OCUL | 67576A100 | $1.8M | 1.10% | 181,588 | SH |
| 34 | EQUILLIUM INC | EQ | 29446K106 | $1.8M | 1.09% | 552,956 | SH |
| 35 | ASCENDIS PHARMA A/S | ASND | K08588103 | $1.8M | 1.08% | 6,573 | SH |
| 36 | CORBUS PHARMACEUTICALS HLDGS | CRBP | 21833P301 | $1.7M | 1.07% | 184,914 | SH |
| 37 | CYTOMX THERAPEUTICS INC. | CTMX | 23284F105 | $1.7M | 1.06% | 460,067 | SH |
| 38 | VERASTEM INC | VSTM | 92337C203 | $1.6M | 1.01% | 429,041 | SH |
| 39 | NEKTAR THERAPEUTICS | NKTR | 640268306 | $1.6M | 0.97% | 22,417 | SH |
| 40 | CLEARPOINT NEURO INC | CLPT | 18507C103 | $1.5M | 0.92% | 83,636 | SH |
| 41 | INSMED INC | INSM | 457669307 | $1.5M | 0.91% | 13,873 | SH |
| 42 | CARIS LIFE SCIENCES INC | CAI | 142152107 | $1.4M | 0.86% | 78,180 | SH |
| 43 | BRIDGEBIO PHARMA INC | BBIO | 10806X102 | $1.4M | 0.84% | 18,359 | SH |
| 44 | ZENAS BIOPHARMA INC | ZBIO | 98937L105 | $1.3M | 0.82% | 52,443 | SH |
| 45 | NOVABRIDGE BIOSCIENCES | NBP | 44975P103 | $1.1M | 0.69% | 576,960 | SH |
| 46 | ESTABLISHMENT LABS HLDGS INC | ESTA | G31249108 | $1.1M | 0.69% | 13,100 | SH |
| 47 | RELAY THERAPEUTICS INC | RLAY | 75943R102 | $889.3K | 0.55% | 47,531 | SH |
| 48 | GERON CORP | GERN | 374163103 | $798.8K | 0.49% | 624,046 | SH |
| 49 | BRIGHT MINDS BIOSCIENCES INC | DRUG | 10919W405 | $709.7K | 0.44% | 10,110 | SH |
| 50 | COMPASS THERAPEUTICS INC | CMPX | 20454B104 | $604.8K | 0.37% | 276,165 | SH |
| Period | Filed | AUM | Holdings | Accession |
|---|---|---|---|---|
| 2026-06-30 | 2026-08-14 | $162.1M | 52 | 0001420506-26-001714 |
| 2026-03-31 | 2026-05-15 | $193.3M | 56 | 0001420506-26-001033 |
| 2025-12-31 | 2026-02-13 | $209.1M | 60 | 0001420506-26-000376 |
| 2025-09-30 | 2025-11-14 | $165.1M | 68 | 0001420506-25-003369 |